Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.62 |
| ▸ | MAPT | P10636 | 8/20 | 0.62 |
| ▸ | HPGD | P15428 | 7/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.62 |
| ▸ | GAA | P10253 | 3/20 | 0.62 |
| ▸ | GLA | P06280 | 1/20 | 0.62 |
| ▸ | CASP1 | P29466 | 1/20 | 0.62 |
| ▸ | CASP7 | P55210 | 1/20 | 0.62 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 3/20 | 0.53 |
| ▸ | CA2 | P00918 | 3/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.53 |
| ▸ | XDH | P47989 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8134690 | 0.87 | SLC2A1 (0.52) | KDM4EALDH1A1MAPTHPGDHSD17B10 | |
| Toluic Acid SCHEMBL15941113 | 0.85 | ALDH1A1 (0.51) | KDM4EALDH1A1MAPTHPGDHSD17B10 | |
| SCHEMBL27501815 | 0.85 | MAPT (0.46) | KDM4EALDH1A1MAPTHPGDHSD17B10 | |
| SCHEMBL31268024 | 0.85 | MAPT (0.68) | KDM4EALDH1A1MAPTHPGDHSD17B10 | |
| SCHEMBL85805 | 0.85 | MAPT (0.68) | KDM4EALDH1A1MAPTHPGDHSD17B10 | |
| SCHEMBL29375113 | 0.84 | KDM4E (0.72) | KDM4EALDH1A1MAPTHPGDHSD17B10 | |
| SCHEMBL192100 | 0.84 | KDM4E (0.72) | KDM4EALDH1A1MAPTHPGDHSD17B10 | |
| SCHEMBL5674062 | 0.83 | MAPT (0.47) | KDM4EALDH1A1MAPTHPGDHSD17B10 | |
| SCHEMBL29648344 | 0.83 | MAPT (0.61) | KDM4EALDH1A1MAPTHPGDHSD17B10 | |
| SCHEMBL27958440 | 0.83 | MAPT (0.44) | KDM4EALDH1A1MAPTHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 602 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118619922-A | Hydroxamic acid compound, and preparation method and application thereof | 郑州大学 | 2024-09-10 | — | — | CN | claimed |
| CN-116730657-B | Cold patch asphalt mixture and preparation method thereof | 芜湖城瑞路桥建设有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-116730657-A | Cold patch asphalt mixture and preparation method thereof | 芜湖城瑞路桥建设有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-109415553-B | Plasticized thermoset resins and related cured resins, curing methods, and articles comprising cured resins | 马萨诸塞大学 | 2022-08-05 | — | — | CN | claimed |
| EP-3396028-B1 | DIRECT ELECTROCHEMICAL SYNTHESIS OF DOPED CONDUCTIVE POLYMERS ON METAL ALLOYS | BOEING CO (US) | 2022-04-06 | — | — | EP | claimed |
| CN-109761817-B | Synthetic method of nefiracetam intermediate 2, 6-dimethylaniline | 深圳市第二人民医院 | 2021-11-16 | — | — | CN | claimed |
| CN-109761817-A | The synthetic method of Nefiracetam intermediate 2,6- dimethylaniline | 深圳市第二人民医院 | 2019-05-17 | — | — | CN | claimed |
| EP-3481899-A1 | PLASTICIZED THERMOSET RESIN, AND ASSOCIATED CURED RESIN, METHOD OF CURING, AND ARTICLE COMPRISING CURED RESIN | The University of Massachusetts (US) | 2019-05-15 | — | — | EP | claimed |
| CN-109415553-A | The thermosetting resin of plasticising and related solidified resin, curing method and the product comprising solidified resin | 马萨诸塞大学 | 2019-03-01 | — | — | CN | claimed |
| WO-2018008003-A1 | PLASTICIZED THERMOSET RESIN, AND ASSOCIATED CURED RESIN, METHOD OF CURING, AND ARTICLE COMPRISING CURED RESIN | THE UNIVERSITY OF MASSACHUSETTS (US) | 2018-01-11 | — | — | WO | claimed |
| US-7211202-B2 | Process to make a conductive composition of a fluorinated polymer which contains polyaniline | ATOFINA (FR) | 2007-05-01 | — | — | US | claimed |
| EP-1428857-B1 | Process to make a conductive composition of a fluorinated polymer which contains polyaniline | ARKEMA FRANCE (FR) | 2007-01-31 | — | — | EP | claimed |
| US-5415893-A | Dispersion of electrically conductive particles in a dispersing medium | DSM N.V. (NL) | 1995-05-16 | — | — | US | claimed |
| JP-7126367-A | — | — | None | — | — | JP | disclosed |
| CN-122036615-A | Indazole hydrazide compound and preparation method and application thereof | 南京农业大学 | 2026-05-15 | — | — | CN | disclosed |
| US-12479836-B2 | Sphingosine-1-phosphate receptor agonist, preparation method therefor, and pharmaceutical composition containing same as active ingredient | LG CHEM, LTD. (KR) | 2025-11-25 | — | — | US | disclosed |
| US-5262483-A | Styrene-maleic anhydride and polyaniline grafted with processability and conductivity | DSM N.V. (NL) | 1993-11-16 | — | — | US | disclosed |
| EP-0538939-A1 | Polymer composition | DSM N.V. (NL) | 1993-04-28 | — | — | EP | disclosed |
| EP-0035393-A1 | Poultry feeds containing and methods of using anovulatory compounds, and novel anovulatory imidazolines | MERCK & CO. INC. (US) | 1981-09-09 | — | — | EP | disclosed |
| US-4287201-A | CONTAINING A 2-(SUBSTITUTED PHENYLIMINO)IMIDAZOLIDINE COMPOUND | MERCK & CO., INC. (US) | 1981-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12479836-B2 | Sphingosine-1-phosphate receptor agonist, preparation method therefor, and pharmaceutical composition containing same as active ingredient | S1PR1, S1PR2, S1PR4 | KDM4E 3159/4885ALDH1A1 2529/4885MAPT 3251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.